For the study, researchers examined commercial claims data for nearly 985,866 courses of oral antibiotics prescribed by 11,986 dermatologists.
Researchers found antibiotic prescriptions fell 36.6 percent between 2008-16, which equates to about 500,000 fewer prescriptions annually. A decline in extended antibiotic courses prescribed for acne and rosacea fueled this decrease. During the same time period, use of antibiotics after surgical visits increased 69.6 percent.
“Overall, our findings are hopefully a sign that we’re making progress, but we need to evaluate how we can optimize the use of antibiotics in dermatologic surgery,” John Barbieri, MD, a dermatology research fellow at Philadelphia-based Penn Medicine, said in a press release.
More articles on clinical leadership and infection control:
Prescribed opioids raise patients’ pneumonia risk
Flu hospitalizations exceed 1K in Colorado
Vaccine production platform wins $10.6M in funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
